Trafalgar International (GCAN) Accumulated Expenses (2016 - 2026)
Greater Cannabis Company (GCAN) posted quarterly Accumulated Expenses of $500350.0 for Q1 2026, up 21.93% year-over-year from $410350.0 in Q1 2025, and up 6.38% quarter-over-quarter from $470350.0 in Q4 2025.
Trafalgar International (GCAN) Accumulated Expenses (2016 - 2026) Analysis & Trends
Greater Cannabis Company's Accumulated Expenses history runs 11 years deep, the most recent figure standing at $500350.0 for Q1 2026.
- In Q1 2026, Accumulated Expenses rose 21.93% year-over-year to $500350.0; the TTM figure through Mar 2026 stood at $500350.0 (up 21.93% YoY), while the FY2025 annual figure was $470350.0, up 500.0% from the prior year.
- Accumulated Expenses for Q1 2026 stood at $500350.0, up from $470350.0 in the prior quarter.
- The five-year high for Accumulated Expenses was $500350.0 in Q1 2026, with the low at $42589.0 in Q4 2022.
- The 5-year median for Accumulated Expenses is $311675.0 (2023), against an average of $269012.4.
- The sharpest annual moves came in 2022 and 2024: Accumulated Expenses jumped 28524.08% in 2022, then sank 79.08% in 2024.
- Greater Cannabis Company's Accumulated Expenses stood at $42589.0 in 2022, then jumped by 30.61% to $55627.0 in 2023, then jumped by 40.92% to $78392.0 in 2024, then soared by 500.0% to $470350.0 in 2025, then increased by 6.38% to $500350.0 in 2026.
- Business Quant data shows GCAN's Accumulated Expenses at $500350.0 in Q1 2026, $470350.0 in Q4 2025, and $460350.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - |
| 10 | Trafalgar International | 236,233.75 | 236,233.75 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 500,350.00 |
| Dec 31, 2025 | 470,350.00 |
| Sep 30, 2025 | 460,350.00 |
| Jun 30, 2025 | 430,350.00 |
| Mar 31, 2025 | 410,350.00 |
| Dec 31, 2024 | 78,392.00 |
| Sep 30, 2024 | 350,350.00 |
| Jun 30, 2024 | 330,350.00 |
| Mar 31, 2024 | 61,287.00 |
| Dec 31, 2023 | 55,627.00 |
| Jun 30, 2023 | 49,828.00 |
| Mar 31, 2023 | 293,000.00 |
| Dec 31, 2022 | 42,589.00 |
| Mar 31, 2022 | 233,000.00 |
| Dec 31, 2021 | 18,199.00 |
| Sep 30, 2021 | 18,462.00 |
| Jun 30, 2021 | 814.00 |
| Mar 31, 2021 | 814.00 |
| Dec 31, 2020 | 16,849.00 |
| Sep 30, 2020 | 18,462.00 |